Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area.
The feasibility of using a sensitive polymerase chain reaction (PCR) to evaluate malaria vaccines in small group sizes was tested in 102 adult Gambian volunteers who received either the malaria vaccine regimen FP9 ME-TRAP/MVA ME-TRAP or rabies vaccine. All volunteers received the antimalarial drugs primaquine and Lapdap plus artesunate to eliminate malaria parasites. Volunteers in a further group received an additional single treatment with sulfadoxine-pyrimethamine (SP) to prevent new infections. There was substantially lower T-cell immunogenicity than in previous trials with this vaccine regimen and no protection against infection in the malaria vaccine group. Using the primary endpoint of 20 parasites per mL, no difference was found in the prevalence of low-level infections in volunteers who received SP compared with those who did not, indicating that SP did not reduce the incidence of very low-density infection. However, SP markedly reduced the incidence of higher density infections. These findings support the feasibility and potential of this approach to screen pre-erythrocytic vaccines for efficacy against infection in small numbers of vaccinees in endemic areas.
Imoukhuede
Egeruan B
EB
Medical Research Council Laboratories, Fajara, The Gambia. ebimoukhuede@hotmail.co.uk
Andrews
Laura
L
Milligan
Paul
P
Berthoud
Tamara
T
Bojang
Kalifa
K
Nwakanma
Davis
D
Ismaili
Jamila
J
Buckee
Caroline
C
Njie
Fanta
F
Keita
Saikou
S
Sowe
Maimuna
M
Lang
Trudie
T
Gilbert
Sarah C
SC
Greenwood
Brian M
BM
Hill
Adrian V S
AV
D000293:Adolescent; D000328:Adult; D006801:Humans; D008288:Malaria / Q000175:diagnosis* / Q000188:drug therapy; D017780:Malaria Vaccines / Q000009:adverse effects / Q000276:immunology*; D008875:Middle Aged; D018512:Parasitemia / Q000175:diagnosis; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D014611:Vaccination
D017780:Malaria Vaccines